Modulation of endothelial cell function by antiphospholipid antibodies.

Abstract

beta 2-glycoprotein I (beta 2-GP-I) the plasma cofactor for anti-phospholipid antibodies adheres on the endothelial surfaces and can be recognized by anti-beta 2-GP-I antibodies naturally occurring in patients with the anti-phospholipid syndrome. As for the cofactor binding to cardiolipin- or gamma irradiated-plates, the endothelial binding is mediated by the so-called phospholipid binding site, a cationic structure able to react with anionic molecules. Endothelial monolayers appear to represent a substrate able to bind beta 2-GP-I and to present it in a suitable manner in order to allow the binding of anti-beta 2-GP-I beta 2 antibodies. The complex between beta 2-GP-I and the respective antibodies induce an endothelial cell activation as demonstrated by the up-regulation of adhesion molecule expression, the secretion of proinflammatory cytokines and the modulation of arachidonic acid metabolism. Taken together these findings strongly sustain a pivotal role for beta 2-GP-I in allowing antibody deposition on the endothelium and in affecting endothelial cell functions potentially responsible for a procoagulant state.

Cite this paper

@article{Meroni1996ModulationOE, title={Modulation of endothelial cell function by antiphospholipid antibodies.}, author={Pier Luigi Meroni and Nicoletta Del Papa and Benedetta Beltrami and Angela Tincani and Genesio Balestrieri and S A Krilis}, journal={Lupus}, year={1996}, volume={5 5}, pages={448-50} }